A case of trichomegaly of the eyelashes and facial hypertrichosis induced by erlotinib (Tarceva®)

International Journal of Dermatology

Volumn 48, Issue 1, 2009, Pages 97-98

  Márquez, Gemma ^a   Herrera Acosta, Enrique ^a   Vidal, Isabel ^a   Galvany, Loida ^a   Iglesias, Maribel ^a   Umbert, Pablo ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; ERLOTINIB; GEMCITABINE;

ADULT; ANAMNESIS; CASE REPORT; ESTHETIC SURGERY; EYEBROW; EYELASH; FEMALE; HAIR GROWTH; HUMAN; HYPERTRICHOSIS; LETTER; LUNG ADENOCARCINOMA; PHYSICAL EXAMINATION; SKIN DISEASE; TRICHOMEGALY;

ADENOCARCINOMA; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; EYELASHES; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTRICHOSIS; LUNG NEOPLASMS; MIDDLE AGED; QUINAZOLINES; RECEPTOR, EPIDERMAL GROWTH FACTOR; RISK ASSESSMENT;

EID: 58149295790     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2009.03752.x     Document Type: Letter

References (7)

1. Jenny C, Parrish S, Lauren C, et al. Cutaneous side effects of epidermal growth factor receptor inhibitors: Clinical presentation, pathogenesis, and management. J Am Acad Dermatol 2007; 56: 317-326.
2. Esther R, María PGM, Eugenio M, et al. Description and management of cutaneous side effects during cetuximab or erlotinib treatments: A prospective study of 30 patients. J Am Acad Dermatol 2006; 55: 429-437.
3. Moyer JD, Barbacci EG, Iwata KK, et al. Induction of apoptosis and cell cycle arrest by CP-358,774, an inhibitor of epidermal growth factor receptor tyrosine kinase. Cancer Res 1997; 57: 4838-4848.
4. Dueland S, Lund-Johansen F, Ostenstad B, et al. Epidermal growth factor receptor inhibition induces trichomegaly. Acta Oncol 2003; 42: 345-346.
5. Pascual JC, Banuls J, Belinchon I, et al. Trichomegaly following treatment with gefitinib (ZD1839). Br J Dermatol 2004; 151: 1111-1112.
6. Bouché O, Brixi-Benmansour H, Bertin A, et al. Trichomegaly of the eyelashes following treatment with cetuximab. Ann Oncol 2005; 16: 1711-1712.
7. Montagut C, Grau JJ, Grimalt R, et al. Abnormal hair growth in a patient with head and neck cancer treated with the anti-epidermal growth factor receptor monoclonal antibody cetuximab. J Clin Oncol 2005; 23: 5273-5275.